- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
EASD
David Cherney, MD: SGLT2 Inhibitors and Prescribing Responsibility
September 28, 2020
An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.
Study Finds Increased Exercise Lowers Mortality Risk 25-32% Among Diabetics
September 25, 2020
A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.
COVID-19 Lockdown May Have Improved Glycemic Control for Some Diabetics
September 23, 2020
Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.
Study Estimates Average Life Years Lost from Type 1, Type 2 Diabetes
September 23, 2020
Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.
Diabetics, Both Type 1 and Type 2, at Increased Risk of Falls, Fall-Related Injuries
September 22, 2020
A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.
Rheumatoid Arthritis Tied to 23% Increase in Risk of New Diabetes
September 22, 2020
A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.